Enfusion Inc (ENFN)
10.10
+0.21
(+2.12%)
USD |
NYSE |
Nov 21, 16:00
10.10
0.00 (0.00%)
Pre-Market: 20:00
Enfusion Revenue (Quarterly): 51.17M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 51.17M |
| June 30, 2024 | 49.46M |
| March 31, 2024 | 48.05M |
| December 31, 2023 | 46.49M |
| September 30, 2023 | 44.36M |
| June 30, 2023 | 42.72M |
| March 31, 2023 | 40.97M |
| December 31, 2022 | 40.52M |
| September 30, 2022 | 39.15M |
| Date | Value |
|---|---|
| June 30, 2022 | 36.54M |
| March 31, 2022 | 34.14M |
| December 31, 2021 | 31.85M |
| September 30, 2021 | 29.04M |
| June 30, 2021 | 26.45M |
| March 31, 2021 | 24.35M |
| December 31, 2020 | 22.66M |
| September 30, 2020 | 19.78M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
19.78M
Minimum
Sep 2020
51.17M
Maximum
Sep 2024
36.92M
Average
39.15M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| F5 Inc | 746.67M |
| Cognizant Technology Solutions Corp | 5.044B |
| Castellum Inc | 11.61M |
| BM Technologies Inc | 14.08M |
| Marti Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.415M |
| Total Expenses (Quarterly) | 48.18M |
| EPS Diluted (Quarterly) | 0.02 |
| Enterprise Value | 931.11M |
| Gross Profit Margin (Quarterly) | 68.06% |
| Profit Margin (Quarterly) | 2.77% |
| Earnings Yield | 0.40% |
| Operating Earnings Yield | 0.56% |
| Normalized Earnings Yield | 0.396 |